van der Burg SH - Search Results

1

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC. Baldwin PJ, et al. Among authors: van der burg sh. Clin Cancer Res. 2003 Nov 1;9(14):5205-13. Clin Cancer Res. 2003. PMID: 14614000 Clinical Trial.

2

p53: a potential target antigen for immunotherapy of cancer.

Offringa R, Vierboom MP, van der Burg SH, Erdile L, Melief CJ. Offringa R, et al. Among authors: van der burg sh. Ann N Y Acad Sci. 2000 Jun;910:223-33; discussion 233-6. doi: 10.1111/j.1749-6632.2000.tb06711.x. Ann N Y Acad Sci. 2000. PMID: 10911916 Review.

3

Design and evaluation of antigen-specific vaccination strategies against cancer.

Offringa R, van der Burg SH, Ossendorp F, Toes RE, Melief CJ. Offringa R, et al. Among authors: van der burg sh. Curr Opin Immunol. 2000 Oct;12(5):576-82. doi: 10.1016/s0952-7915(00)00145-x. Curr Opin Immunol. 2000. PMID: 11007362 Review.

4

Identification of three non-VNTR MUC1-derived HLA-A*0201-restricted T-cell epitopes that induce protective anti-tumor immunity in HLA-A2/K(b)-transgenic mice.

Heukamp LC, van der Burg SH, Drijfhout JW, Melief CJ, Taylor-Papadimitriou J, Offringa R. Heukamp LC, et al. Among authors: van der burg sh. Int J Cancer. 2001 Feb 1;91(3):385-92. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1051>3.0.co;2-z. Int J Cancer. 2001. PMID: 11169964

5

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

van der Burg SH, Ressing ME, Kwappenberg KM, de Jong A, Straathof K, de Jong J, Geluk A, van Meijgaarden KE, Franken KL, Ottenhoff TH, Fleuren GJ, Kenter G, Melief CJ, Offringa R. van der Burg SH, et al. Among authors: van meijgaarden ke. Int J Cancer. 2001 Mar 1;91(5):612-8. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1119>3.0.co;2-c. Int J Cancer. 2001. PMID: 11267969

6

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens.

van der Burg SH, Kwappenberg KM, O'Neill T, Brandt RM, Melief CJ, Hickling JK, Offringa R. van der Burg SH, et al. Vaccine. 2001 Jun 14;19(27):3652-60. doi: 10.1016/s0264-410x(01)00086-x. Vaccine. 2001. PMID: 11395199

7

Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.

de Jong A, van der Burg SH, Kwappenberg KM, van der Hulst JM, Franken KL, Geluk A, van Meijgaarden KE, Drijfhout JW, Kenter G, Vermeij P, Melief CJ, Offringa R. de Jong A, et al. Among authors: van meijgaarden ke, van der hulst jm, van der burg sh. Cancer Res. 2002 Jan 15;62(2):472-9. Cancer Res. 2002. PMID: 11809698

8

Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine.

van der Burg SH, Menon AG, Redeker A, Bonnet MC, Drijfhout JW, Tollenaar RA, van de Velde CJ, Moingeon P, Kuppen PJ, Offringa R, Melief CJ. van der Burg SH, et al. Among authors: van de velde cj. Clin Cancer Res. 2002 May;8(5):1019-27. Clin Cancer Res. 2002. PMID: 12006514 Clinical Trial.

9

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.

Zwaveling S, Ferreira Mota SC, Nouta J, Johnson M, Lipford GB, Offringa R, van der Burg SH, Melief CJ. Zwaveling S, et al. Among authors: van der burg sh. J Immunol. 2002 Jul 1;169(1):350-8. doi: 10.4049/jimmunol.169.1.350. J Immunol. 2002. PMID: 12077264

10

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine.

de Jong A, O'Neill T, Khan AY, Kwappenberg KM, Chisholm SE, Whittle NR, Dobson JA, Jack LC, St Clair Roberts JA, Offringa R, van der Burg SH, Hickling JK. de Jong A, et al. Among authors: van der burg sh. Vaccine. 2002 Oct 4;20(29-30):3456-64. doi: 10.1016/s0264-410x(02)00350-x. Vaccine. 2002. PMID: 12297390 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters